(Q61651658)
English
T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated don
scientific article published on 01 October 2003
Statements
T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusions (English)
Geoff Hale
Anthony Goldstone
Karl Peggs
Stephanie Verfuerth
Dharsha Thuraisundaram
Michael Watts
Stephen Mackinnon